Source:http://linkedlifedata.com/resource/pubmed/id/15838989
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-4-19
|
pubmed:abstractText |
A single antibody-incubation step of an indirect, enzyme-linked immunosorbent assay (ELISA) was performed during microgravity, Martian gravity (0.38 G) and hypergravity (1.8 G) phases of parabolic flight, onboard the NASA KC-135 aircraft. Antibody-antigen binding occurred within 15 seconds; the level of binding did not differ between microgravity, Martian gravity and 1 G (Earth's gravity) conditions. During hypergravity and 1 G, antibody binding was directly proportional to the fluid volume (per microtiter well) used for incubation; this pattern was not observed during microgravity. These effects in microgravity may be due to "fluid spread" within the chamber (observed during microgravity with digital photography), leading to greater fluid-surface contact and subsequently antibody-antigen contact. In summary, these results demonstrate that: i) ELISA antibody-incubation and washing steps can be successfully performed by human operators during microgravity, Martian gravity and hypergravity; ii) there is no significant difference in antibody binding between microgravity, Martian gravity and 1 G conditions; and iii) a smaller fluid volume/well (and therefore less antibody) was required for a given level of binding during microgravity. These conclusions indicate that reduced gravity would not present a barrier to successful operation of immunosorbent assays during spaceflight.
|
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
S
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1077-9248
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NASA
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
47-55
|
pubmed:meshHeading |
pubmed-meshheading:15838989-Antigen-Antibody Reactions,
pubmed-meshheading:15838989-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15838989-Gravity, Altered,
pubmed-meshheading:15838989-Hypergravity,
pubmed-meshheading:15838989-Rheology,
pubmed-meshheading:15838989-Space Flight,
pubmed-meshheading:15838989-Weightlessness,
pubmed-meshheading:15838989-beta-Galactosidase
|
pubmed:year |
2003
|
pubmed:articleTitle |
Antibody binding in altered gravity: implications for immunosorbent assay during space flight.
|
pubmed:affiliation |
Geophysical Laboratory, Carnegie Institution of Washington, Washington, DC, USA. Jake.Maule@jsc.nasa.gov
|
pubmed:publicationType |
Journal Article
|